Cargando…

The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges

BACKGROUND: Hepatitis C infection (HCV) can have a harmful effect on the health of people and can impose relevant healthcare costs. The World Health Organization has identified the elimination of Hepatitis C by 2030 as an important goal for all countries. This study aimed to identify the HCV-related...

Descripción completa

Detalles Bibliográficos
Autores principales: BEHZADIFAR, M., AZARI, S., GORJI, H.A., MARTINI, M., BRAGAZZI, N.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225642/
https://www.ncbi.nlm.nih.gov/pubmed/32490276
http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.1.1438
_version_ 1783534112779272192
author BEHZADIFAR, M.
AZARI, S.
GORJI, H.A.
MARTINI, M.
BRAGAZZI, N.L.
author_facet BEHZADIFAR, M.
AZARI, S.
GORJI, H.A.
MARTINI, M.
BRAGAZZI, N.L.
author_sort BEHZADIFAR, M.
collection PubMed
description BACKGROUND: Hepatitis C infection (HCV) can have a harmful effect on the health of people and can impose relevant healthcare costs. The World Health Organization has identified the elimination of Hepatitis C by 2030 as an important goal for all countries. This study aimed to identify the HCV-related policies in Iran. METHODS: A qualitative approach was used for this study. Data was collected through a comprehensive search of documents and interviews with different stakeholders related to the HCV program. Data was analyzed and validated using content analysis based on the policy triangle framework. RESULTS: Our findings highlighted that certain social and cultural issues related to stigma can impact on awareness-raising processes. It is also necessary to consider HCV directly in the context of government policies. All relevant stakeholders should be included. Continued talks and interactions need to be made between them for the active participation of all actors. CONCLUSION: The findings of this study can provide useful information for improving, supporting and developing policy processes. Healthcare providers should address all aspects of the disease by 2030 in order to achieve the goal of HCV elimination. Evidence-based planning, support for up-to-date policies and resource mobilization are needed to achieve this ambitious goal.
format Online
Article
Text
id pubmed-7225642
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Pacini Editore Srl
record_format MEDLINE/PubMed
spelling pubmed-72256422020-06-01 The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges BEHZADIFAR, M. AZARI, S. GORJI, H.A. MARTINI, M. BRAGAZZI, N.L. J Prev Med Hyg Review BACKGROUND: Hepatitis C infection (HCV) can have a harmful effect on the health of people and can impose relevant healthcare costs. The World Health Organization has identified the elimination of Hepatitis C by 2030 as an important goal for all countries. This study aimed to identify the HCV-related policies in Iran. METHODS: A qualitative approach was used for this study. Data was collected through a comprehensive search of documents and interviews with different stakeholders related to the HCV program. Data was analyzed and validated using content analysis based on the policy triangle framework. RESULTS: Our findings highlighted that certain social and cultural issues related to stigma can impact on awareness-raising processes. It is also necessary to consider HCV directly in the context of government policies. All relevant stakeholders should be included. Continued talks and interactions need to be made between them for the active participation of all actors. CONCLUSION: The findings of this study can provide useful information for improving, supporting and developing policy processes. Healthcare providers should address all aspects of the disease by 2030 in order to achieve the goal of HCV elimination. Evidence-based planning, support for up-to-date policies and resource mobilization are needed to achieve this ambitious goal. Pacini Editore Srl 2020-04-02 /pmc/articles/PMC7225642/ /pubmed/32490276 http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.1.1438 Text en ©2020 Pacini Editore SRL, Pisa, Italy https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-Non-Commercial-NoDerivatives 4.0 International) license. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
spellingShingle Review
BEHZADIFAR, M.
AZARI, S.
GORJI, H.A.
MARTINI, M.
BRAGAZZI, N.L.
The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges
title The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges
title_full The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges
title_fullStr The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges
title_full_unstemmed The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges
title_short The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges
title_sort hepatitis c virus in iran: health policy, historical, ethical issues and future challenges
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225642/
https://www.ncbi.nlm.nih.gov/pubmed/32490276
http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.1.1438
work_keys_str_mv AT behzadifarm thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges
AT azaris thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges
AT gorjiha thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges
AT martinim thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges
AT bragazzinl thehepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges
AT behzadifarm hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges
AT azaris hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges
AT gorjiha hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges
AT martinim hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges
AT bragazzinl hepatitiscvirusiniranhealthpolicyhistoricalethicalissuesandfuturechallenges